Clinical Trial Update: A Clinical Trial of Acamprosate for Treatment of Methamphetamine Addiction [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated acamprosate for methamphetamine use disorder in treatment-seeking individuals; the study is completed and results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder

Drugs mentioned

• acamprosate (acamprosate)

Snippet

Sponsor: NYU Langone Health | Conditions: Methamphetamine Dependence, Treatment Seeking | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-04-06